Bill
HR 3029
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
119th Congress
Introduced by Sarah McBride and 3 co-sponsors
HR 3029 sets strict standards for handling nucleic acids to enhance biosecurity, impacting research institutions and biotech firms while ensuring public safety.
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.